NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model

A new National Institutes of Health (NIH)─funded study indicates that the experimental drug kamuvudine─9 (K─9) facilitates recovery from pre─existing vision loss and paralysis in animal models of multiple sclerosis